TAVI ANCHORING ASSIST DEVICE
    63.
    发明申请
    TAVI ANCHORING ASSIST DEVICE 审中-公开
    TAVI锚固辅助装置

    公开(公告)号:US20160256270A1

    公开(公告)日:2016-09-08

    申请号:US15060258

    申请日:2016-03-03

    Abstract: An implant system may include a delivery sheath having an actuator mechanism, an anchoring assistance device including an expandable scaffold including a mid-body section, a cusp interface section, and a crown end arrangement, and a replacement heart valve implant. The cusp interface section includes a plurality of loop portions arranged at radial intervals about the expandable scaffold. Each loop portion is circumferentially spaced apart from another loop portion by a region having a deployment ring, the region being configured to span a commissure of the aortic valve and extending distally a shorter distance from the distal end than the loop portions. An elongate deployment member is configured to releasably engage with the deployment rings to actuate the expandable scaffold from a delivery configuration to a deployed configuration. The replacement heart valve implant is configured to be at least partially disposed within the expandable scaffold in the deployed configuration.

    Abstract translation: 植入系统可以包括具有致动器机构的输送护套,包括可扩展支架的锚固辅助装置,所述支架包括中体部分,尖部接合部分和冠部端部布置,以及置换心脏瓣膜植入物。 尖端界面部分包括围绕可膨胀支架以径向间隔布置的多个环部分。 每个环部分与另一个环部分周向间隔开具有展开环的区域,所述区域构造成跨越主动脉瓣的连接并且从远端延伸离开远端比环路部分更短的距离。 细长展开构件构造成可释放地与展开环接合,以将可扩展支架从输送构型驱动到展开构型。 置换心脏瓣膜植入物构造成在展开构型中至少部分地设置在可扩展支架内。

    STENTS WITH LINER FACILITATING STENT REMOVAL AND METHODS OF USE

    公开(公告)号:US20250049599A1

    公开(公告)日:2025-02-13

    申请号:US18927283

    申请日:2024-10-25

    Inventor: Martyn G. Folan

    Abstract: An implantable treatment device configured to facilitate removal thereof after tissue ingrowth into a portion thereof, such as into an enlarged region with a diameter greater than adjacent regions. A liner is positioned within a lumen of the treatment device, with a portion spaced from the enlarged region of the treatment device. A disruption zone in the liner facilitates controlled disruption of the liner's integrity to permit a portion of a removal device inserted within the liner to extend through the liner to interact with the treatment device. The treatment device may be part of a treatment system including a removal device with an enlarged region corresponding to the treatment device enlarged region. A method of treatment involves rupturing a rupture zone in a treatment device liner to allow a portion of a removal device to extend through the liner and into engagement with a portion of the treatment device.

    Stent
    66.
    发明授权
    Stent 有权

    公开(公告)号:US12213899B2

    公开(公告)日:2025-02-04

    申请号:US18402217

    申请日:2024-01-02

    Abstract: An illustrative stent may comprise an elongated tubular member having a first end and a second end and an intermediate region disposed therebetween. The elongated tubular member configured to move between a collapsed configuration and an expanded configuration. The elongated tubular member may comprise at least one twisted filament, such as a knitted filament having a plurality of twisted knit stitches with intermediate rung portions extending between adjacent twisted knit stitches, or a plurality of helical filaments twisted with a plurality of longitudinal filaments.

    STENT WITH ANTI-OCCLUSION SYSTEM
    67.
    发明申请

    公开(公告)号:US20250025281A1

    公开(公告)日:2025-01-23

    申请号:US18774348

    申请日:2024-07-16

    Abstract: An illustrative stent includes an elongated tubular member comprising at least one strut forming a tubular wall having a plurality of cells extending through a thickness of the tubular wall. The elongated tubular member may be configured to move between a radially collapsed configuration and a radially expanded configuration. A coating may be disposed on the elongated tubular member and spanning at least some of the plurality of cells. One or more magnetic components may be disposed on or within the coating.

Patent Agency Ranking